JPH0443697B2 - - Google Patents
Info
- Publication number
- JPH0443697B2 JPH0443697B2 JP61202661A JP20266186A JPH0443697B2 JP H0443697 B2 JPH0443697 B2 JP H0443697B2 JP 61202661 A JP61202661 A JP 61202661A JP 20266186 A JP20266186 A JP 20266186A JP H0443697 B2 JPH0443697 B2 JP H0443697B2
- Authority
- JP
- Japan
- Prior art keywords
- urea
- group
- imidazole
- adsorbent
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 82
- 239000004202 carbamide Substances 0.000 claims description 81
- 239000003463 adsorbent Substances 0.000 claims description 55
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 49
- 125000002883 imidazolyl group Chemical group 0.000 claims description 44
- 229920000642 polymer Polymers 0.000 claims description 39
- 239000000178 monomer Substances 0.000 claims description 37
- 239000003431 cross linking reagent Substances 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 9
- 229910052739 hydrogen Inorganic materials 0.000 claims description 9
- 239000000470 constituent Substances 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 6
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000003827 glycol group Chemical group 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 31
- 238000001179 sorption measurement Methods 0.000 description 29
- ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 21
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 19
- -1 ethylene, propylene, 1-butene Chemical class 0.000 description 17
- 238000006116 polymerization reaction Methods 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 14
- OSSNTDFYBPYIEC-UHFFFAOYSA-N 1-ethenylimidazole Chemical compound C=CN1C=CN=C1 OSSNTDFYBPYIEC-UHFFFAOYSA-N 0.000 description 11
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 10
- 210000003734 kidney Anatomy 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- 238000000862 absorption spectrum Methods 0.000 description 9
- 150000002334 glycols Chemical class 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 7
- 229920006037 cross link polymer Polymers 0.000 description 7
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 230000002522 swelling effect Effects 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- MHQZDNQHLGFBRN-UHFFFAOYSA-N 5-ethenyl-1h-imidazole Chemical compound C=CC1=CNC=N1 MHQZDNQHLGFBRN-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 3
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000010528 free radical solution polymerization reaction Methods 0.000 description 3
- 150000002430 hydrocarbons Chemical group 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000379 polymerizing effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 2
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N 1-Heptene Chemical compound CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 2
- UZKWTJUDCOPSNM-UHFFFAOYSA-N 1-ethenoxybutane Chemical compound CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 2
- UAJRSHJHFRVGMG-UHFFFAOYSA-N 1-ethenyl-4-methoxybenzene Chemical compound COC1=CC=C(C=C)C=C1 UAJRSHJHFRVGMG-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N 1-nonene Chemical compound CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 2
- JLIDVCMBCGBIEY-UHFFFAOYSA-N 1-penten-3-one Chemical compound CCC(=O)C=C JLIDVCMBCGBIEY-UHFFFAOYSA-N 0.000 description 2
- YYPNJNDODFVZLE-UHFFFAOYSA-N 3-methylbut-2-enoic acid Chemical compound CC(C)=CC(O)=O YYPNJNDODFVZLE-UHFFFAOYSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- IAQRGUVFOMOMEM-UHFFFAOYSA-N but-2-ene Chemical compound CC=CC IAQRGUVFOMOMEM-UHFFFAOYSA-N 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- FUSUHKVFWTUUBE-UHFFFAOYSA-N buten-2-one Chemical compound CC(=O)C=C FUSUHKVFWTUUBE-UHFFFAOYSA-N 0.000 description 2
- RWGFKTVRMDUZSP-UHFFFAOYSA-N cumene Chemical compound CC(C)C1=CC=CC=C1 RWGFKTVRMDUZSP-UHFFFAOYSA-N 0.000 description 2
- FJKIXWOMBXYWOQ-UHFFFAOYSA-N ethenoxyethane Chemical compound CCOC=C FJKIXWOMBXYWOQ-UHFFFAOYSA-N 0.000 description 2
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- VHRYZQNGTZXDNX-UHFFFAOYSA-N methacryloyl chloride Chemical compound CC(=C)C(Cl)=O VHRYZQNGTZXDNX-UHFFFAOYSA-N 0.000 description 2
- JTHNLKXLWOXOQK-UHFFFAOYSA-N n-propyl vinyl ketone Natural products CCCC(=O)C=C JTHNLKXLWOXOQK-UHFFFAOYSA-N 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 150000002978 peroxides Chemical class 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000012966 redox initiator Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- UAXOELSVPTZZQG-UHFFFAOYSA-N tiglic acid Natural products CC(C)=C(C)C(O)=O UAXOELSVPTZZQG-UHFFFAOYSA-N 0.000 description 2
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 2
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- NIONDZDPPYHYKY-SNAWJCMRSA-N (2E)-hexenoic acid Chemical compound CCC\C=C\C(O)=O NIONDZDPPYHYKY-SNAWJCMRSA-N 0.000 description 1
- HMYXKHZCEYROAL-UHFFFAOYSA-N (4-chloro-2,3,5,6-tetrafluorophenyl)methanol Chemical compound OCC1=C(F)C(F)=C(Cl)C(F)=C1F HMYXKHZCEYROAL-UHFFFAOYSA-N 0.000 description 1
- ADLXTJMPCFOTOO-UHFFFAOYSA-N (E)-2-Nonenoic acid Natural products CCCCCCC=CC(O)=O ADLXTJMPCFOTOO-UHFFFAOYSA-N 0.000 description 1
- ADLXTJMPCFOTOO-BQYQJAHWSA-N (E)-non-2-enoic acid Chemical compound CCCCCC\C=C\C(O)=O ADLXTJMPCFOTOO-BQYQJAHWSA-N 0.000 description 1
- IICQZTQZQSBHBY-HWKANZROSA-N (e)-non-2-ene Chemical compound CCCCCC\C=C\C IICQZTQZQSBHBY-HWKANZROSA-N 0.000 description 1
- IBUCWFAQJINUGP-UHFFFAOYSA-N 1-(1h-imidazol-2-yl)-2-methylprop-2-en-1-one Chemical class CC(=C)C(=O)C1=NC=CN1 IBUCWFAQJINUGP-UHFFFAOYSA-N 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- HMDQPBSDHHTRNI-UHFFFAOYSA-N 1-(chloromethyl)-3-ethenylbenzene Chemical compound ClCC1=CC=CC(C=C)=C1 HMDQPBSDHHTRNI-UHFFFAOYSA-N 0.000 description 1
- ZRZHXNCATOYMJH-UHFFFAOYSA-N 1-(chloromethyl)-4-ethenylbenzene Chemical compound ClCC1=CC=C(C=C)C=C1 ZRZHXNCATOYMJH-UHFFFAOYSA-N 0.000 description 1
- GXVWSABOPZBCGK-UHFFFAOYSA-N 1-butyl-5-ethenylimidazole Chemical compound CCCCN1C=NC=C1C=C GXVWSABOPZBCGK-UHFFFAOYSA-N 0.000 description 1
- BOVQCIDBZXNFEJ-UHFFFAOYSA-N 1-chloro-3-ethenylbenzene Chemical compound ClC1=CC=CC(C=C)=C1 BOVQCIDBZXNFEJ-UHFFFAOYSA-N 0.000 description 1
- KTZVZZJJVJQZHV-UHFFFAOYSA-N 1-chloro-4-ethenylbenzene Chemical compound ClC1=CC=C(C=C)C=C1 KTZVZZJJVJQZHV-UHFFFAOYSA-N 0.000 description 1
- OVGRCEFMXPHEBL-UHFFFAOYSA-N 1-ethenoxypropane Chemical compound CCCOC=C OVGRCEFMXPHEBL-UHFFFAOYSA-N 0.000 description 1
- VTPNYMSKBPZSTF-UHFFFAOYSA-N 1-ethenyl-2-ethylbenzene Chemical compound CCC1=CC=CC=C1C=C VTPNYMSKBPZSTF-UHFFFAOYSA-N 0.000 description 1
- NVZWEEGUWXZOKI-UHFFFAOYSA-N 1-ethenyl-2-methylbenzene Chemical compound CC1=CC=CC=C1C=C NVZWEEGUWXZOKI-UHFFFAOYSA-N 0.000 description 1
- VKVLTUQLNXVANB-UHFFFAOYSA-N 1-ethenyl-2-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1C=C VKVLTUQLNXVANB-UHFFFAOYSA-N 0.000 description 1
- XHUZSRRCICJJCN-UHFFFAOYSA-N 1-ethenyl-3-ethylbenzene Chemical compound CCC1=CC=CC(C=C)=C1 XHUZSRRCICJJCN-UHFFFAOYSA-N 0.000 description 1
- PECUPOXPPBBFLU-UHFFFAOYSA-N 1-ethenyl-3-methoxybenzene Chemical compound COC1=CC=CC(C=C)=C1 PECUPOXPPBBFLU-UHFFFAOYSA-N 0.000 description 1
- JZHGRUMIRATHIU-UHFFFAOYSA-N 1-ethenyl-3-methylbenzene Chemical compound CC1=CC=CC(C=C)=C1 JZHGRUMIRATHIU-UHFFFAOYSA-N 0.000 description 1
- WHFHDVDXYKOSKI-UHFFFAOYSA-N 1-ethenyl-4-ethylbenzene Chemical compound CCC1=CC=C(C=C)C=C1 WHFHDVDXYKOSKI-UHFFFAOYSA-N 0.000 description 1
- YFZHODLXYNDBSM-UHFFFAOYSA-N 1-ethenyl-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(C=C)C=C1 YFZHODLXYNDBSM-UHFFFAOYSA-N 0.000 description 1
- ATQUFXWBVZUTKO-UHFFFAOYSA-N 1-methylcyclopentene Chemical compound CC1=CCCC1 ATQUFXWBVZUTKO-UHFFFAOYSA-N 0.000 description 1
- KUIZKZHDMPERHR-UHFFFAOYSA-N 1-phenylprop-2-en-1-one Chemical compound C=CC(=O)C1=CC=CC=C1 KUIZKZHDMPERHR-UHFFFAOYSA-N 0.000 description 1
- XMNIXWIUMCBBBL-UHFFFAOYSA-N 2-(2-phenylpropan-2-ylperoxy)propan-2-ylbenzene Chemical compound C=1C=CC=CC=1C(C)(C)OOC(C)(C)C1=CC=CC=C1 XMNIXWIUMCBBBL-UHFFFAOYSA-N 0.000 description 1
- OTTZHAVKAVGASB-HYXAFXHYSA-N 2-Heptene Chemical compound CCCC\C=C/C OTTZHAVKAVGASB-HYXAFXHYSA-N 0.000 description 1
- UIERETOOQGIECD-ARJAWSKDSA-M 2-Methyl-2-butenoic acid Natural products C\C=C(\C)C([O-])=O UIERETOOQGIECD-ARJAWSKDSA-M 0.000 description 1
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 description 1
- CFVZILWIXKITDD-UHFFFAOYSA-N 2-acetyloxyprop-2-enoic acid Chemical compound CC(=O)OC(=C)C(O)=O CFVZILWIXKITDD-UHFFFAOYSA-N 0.000 description 1
- FEUFEGJTJIHPOF-UHFFFAOYSA-N 2-butyl acrylic acid Chemical compound CCCCC(=C)C(O)=O FEUFEGJTJIHPOF-UHFFFAOYSA-N 0.000 description 1
- ISRGONDNXBCDBM-UHFFFAOYSA-N 2-chlorostyrene Chemical compound ClC1=CC=CC=C1C=C ISRGONDNXBCDBM-UHFFFAOYSA-N 0.000 description 1
- PGYJSURPYAAOMM-UHFFFAOYSA-N 2-ethenoxy-2-methylpropane Chemical compound CC(C)(C)OC=C PGYJSURPYAAOMM-UHFFFAOYSA-N 0.000 description 1
- PIUJWWBOMGMSAY-UHFFFAOYSA-N 2-ethenoxybutane Chemical compound CCC(C)OC=C PIUJWWBOMGMSAY-UHFFFAOYSA-N 0.000 description 1
- PZBASOPBSCAZSR-UHFFFAOYSA-N 2-ethenyl-1-methylimidazole Chemical compound CN1C=CN=C1C=C PZBASOPBSCAZSR-UHFFFAOYSA-N 0.000 description 1
- MLMGJTAJUDSUKA-UHFFFAOYSA-N 2-ethenyl-1h-imidazole Chemical compound C=CC1=NC=CN1 MLMGJTAJUDSUKA-UHFFFAOYSA-N 0.000 description 1
- XUDBVJCTLZTSDC-UHFFFAOYSA-N 2-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=CC=C1C=C XUDBVJCTLZTSDC-UHFFFAOYSA-N 0.000 description 1
- SLENVLASKTZHDW-UHFFFAOYSA-N 2-ethenylbenzonitrile Chemical compound C=CC1=CC=CC=C1C#N SLENVLASKTZHDW-UHFFFAOYSA-N 0.000 description 1
- RDQQZSMXQAMRFQ-UHFFFAOYSA-N 2-ethoxyethenyl acetate Chemical compound CCOC=COC(C)=O RDQQZSMXQAMRFQ-UHFFFAOYSA-N 0.000 description 1
- WROUWQQRXUBECT-UHFFFAOYSA-N 2-ethylacrylic acid Chemical compound CCC(=C)C(O)=O WROUWQQRXUBECT-UHFFFAOYSA-N 0.000 description 1
- NEYTTWNDEATJBU-UHFFFAOYSA-N 2-ethylpent-2-enoic acid Chemical compound CCC=C(CC)C(O)=O NEYTTWNDEATJBU-UHFFFAOYSA-N 0.000 description 1
- OTTZHAVKAVGASB-UHFFFAOYSA-N 2-heptene Natural products CCCCC=CC OTTZHAVKAVGASB-UHFFFAOYSA-N 0.000 description 1
- YURNCBVQZBJDAJ-UHFFFAOYSA-N 2-heptenoic acid Chemical compound CCCCC=CC(O)=O YURNCBVQZBJDAJ-UHFFFAOYSA-N 0.000 description 1
- IRUDSQHLKGNCGF-UHFFFAOYSA-N 2-methylhex-1-ene Chemical compound CCCCC(C)=C IRUDSQHLKGNCGF-UHFFFAOYSA-N 0.000 description 1
- PIAOLBVUVDXHHL-UHFFFAOYSA-N 2-nitroethenylbenzene Chemical compound [O-][N+](=O)C=CC1=CC=CC=C1 PIAOLBVUVDXHHL-UHFFFAOYSA-N 0.000 description 1
- ILPBINAXDRFYPL-UHFFFAOYSA-N 2-octene Chemical compound CCCCCC=CC ILPBINAXDRFYPL-UHFFFAOYSA-N 0.000 description 1
- WXBXVVIUZANZAU-UHFFFAOYSA-N 2E-decenoic acid Natural products CCCCCCCC=CC(O)=O WXBXVVIUZANZAU-UHFFFAOYSA-N 0.000 description 1
- IICQZTQZQSBHBY-UHFFFAOYSA-N 2t-nonene Natural products CCCCCCC=CC IICQZTQZQSBHBY-UHFFFAOYSA-N 0.000 description 1
- SGCFZIQBVRYXOZ-UHFFFAOYSA-N 3-but-3-enoyl-2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(C(=O)CC=C)=C1O SGCFZIQBVRYXOZ-UHFFFAOYSA-N 0.000 description 1
- BZPQHHYKWTUHLK-UHFFFAOYSA-N 3-ethenyl-2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(C=C)=C1O BZPQHHYKWTUHLK-UHFFFAOYSA-N 0.000 description 1
- FDIHXBYYQCPWDX-UHFFFAOYSA-N 3-ethenylbenzonitrile Chemical compound C=CC1=CC=CC(C#N)=C1 FDIHXBYYQCPWDX-UHFFFAOYSA-N 0.000 description 1
- RYKZRKKEYSRDNF-UHFFFAOYSA-N 3-methylidenepentane Chemical compound CCC(=C)CC RYKZRKKEYSRDNF-UHFFFAOYSA-N 0.000 description 1
- JLBJTVDPSNHSKJ-UHFFFAOYSA-N 4-Methylstyrene Chemical compound CC1=CC=C(C=C)C=C1 JLBJTVDPSNHSKJ-UHFFFAOYSA-N 0.000 description 1
- WLPQGZNMXPKVBI-UHFFFAOYSA-N 4-ethenyl-2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(C=C)C=C1O WLPQGZNMXPKVBI-UHFFFAOYSA-N 0.000 description 1
- IRQWEODKXLDORP-UHFFFAOYSA-N 4-ethenylbenzoic acid Chemical compound OC(=O)C1=CC=C(C=C)C=C1 IRQWEODKXLDORP-UHFFFAOYSA-N 0.000 description 1
- SNTUCKQYWGHZPK-UHFFFAOYSA-N 4-ethenylbenzonitrile Chemical compound C=CC1=CC=C(C#N)C=C1 SNTUCKQYWGHZPK-UHFFFAOYSA-N 0.000 description 1
- QAOXMQCWUWZZNC-ARJAWSKDSA-N 4-methyl-2-pentenoic acid Chemical compound CC(C)\C=C/C(O)=O QAOXMQCWUWZZNC-ARJAWSKDSA-N 0.000 description 1
- SNOYUTZWILESAI-UHFFFAOYSA-N 4-methylpent-1-en-3-one Chemical compound CC(C)C(=O)C=C SNOYUTZWILESAI-UHFFFAOYSA-N 0.000 description 1
- PXKMUNNPCVXVGE-UHFFFAOYSA-N 5-ethenyl-1-ethylimidazole Chemical compound CCN1C=NC=C1C=C PXKMUNNPCVXVGE-UHFFFAOYSA-N 0.000 description 1
- AUHSAHIUCMNMLS-UHFFFAOYSA-N 5-ethenyl-1-methylimidazole Chemical compound CN1C=NC=C1C=C AUHSAHIUCMNMLS-UHFFFAOYSA-N 0.000 description 1
- UPDOXQRIQXUXBK-UHFFFAOYSA-N 5-ethenyl-1-propylimidazole Chemical compound CCCN1C=NC=C1C=C UPDOXQRIQXUXBK-UHFFFAOYSA-N 0.000 description 1
- UHIWSJXHUHEAMG-UHFFFAOYSA-N 5-ethenyl-2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC(C=C)=CC=C1O UHIWSJXHUHEAMG-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- UIERETOOQGIECD-UHFFFAOYSA-N Angelic acid Natural products CC=C(C)C(O)=O UIERETOOQGIECD-UHFFFAOYSA-N 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- KXGSNGSKZDUCAJ-UHFFFAOYSA-N C(=C)CC(=O)C1=CC=C(C(C(=O)O)=C1)O Chemical compound C(=C)CC(=O)C1=CC=C(C(C(=O)O)=C1)O KXGSNGSKZDUCAJ-UHFFFAOYSA-N 0.000 description 1
- ARIKESCMAVVVQL-UHFFFAOYSA-N C(=C)CC(=O)C=1C=C(C(C(=O)O)=CC=1)O Chemical compound C(=C)CC(=O)C=1C=C(C(C(=O)O)=CC=1)O ARIKESCMAVVVQL-UHFFFAOYSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- YIVJZNGAASQVEM-UHFFFAOYSA-N Lauroyl peroxide Chemical compound CCCCCCCCCCCC(=O)OOC(=O)CCCCCCCCCCC YIVJZNGAASQVEM-UHFFFAOYSA-N 0.000 description 1
- GYCMBHHDWRMZGG-UHFFFAOYSA-N Methylacrylonitrile Chemical compound CC(=C)C#N GYCMBHHDWRMZGG-UHFFFAOYSA-N 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical group ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- OLYAJUIZHQSQRP-HWKANZROSA-N [(e)-pent-2-enyl]benzene Chemical compound CC\C=C\CC1=CC=CC=C1 OLYAJUIZHQSQRP-HWKANZROSA-N 0.000 description 1
- ASAPXSLRMDUMFX-QXMHVHEDSA-N [(z)-octadec-9-enyl] prop-2-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)C=C ASAPXSLRMDUMFX-QXMHVHEDSA-N 0.000 description 1
- YSVZGWAJIHWNQK-UHFFFAOYSA-N [3-(hydroxymethyl)-2-bicyclo[2.2.1]heptanyl]methanol Chemical compound C1CC2C(CO)C(CO)C1C2 YSVZGWAJIHWNQK-UHFFFAOYSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- SRUCYNCHUFMZIT-UHFFFAOYSA-N acetyl prop-2-enoate Chemical compound CC(=O)OC(=O)C=C SRUCYNCHUFMZIT-UHFFFAOYSA-N 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000005456 alcohol based solvent Substances 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- YIYBQIKDCADOSF-UHFFFAOYSA-N alpha-Butylen-alpha-carbonsaeure Natural products CCC=CC(O)=O YIYBQIKDCADOSF-UHFFFAOYSA-N 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- ZAVUGVPMYAZPGN-UHFFFAOYSA-N benzoyl benzenecarboperoxoate;n,n-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1.C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 ZAVUGVPMYAZPGN-UHFFFAOYSA-N 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 238000012662 bulk polymerization Methods 0.000 description 1
- VIHAEDVKXSOUAT-UHFFFAOYSA-N but-2-en-4-olide Chemical compound O=C1OCC=C1 VIHAEDVKXSOUAT-UHFFFAOYSA-N 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- KTVZZJJSXSGJSX-UHFFFAOYSA-N carbonic acid;2-propan-2-ylperoxypropane Chemical compound OC(O)=O.CC(C)OOC(C)C KTVZZJJSXSGJSX-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- ZXIJMRYMVAMXQP-UHFFFAOYSA-N cycloheptene Chemical compound C1CCC=CCC1 ZXIJMRYMVAMXQP-UHFFFAOYSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- FWLDHHJLVGRRHD-UHFFFAOYSA-N decyl prop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C=C FWLDHHJLVGRRHD-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- LSXWFXONGKSEMY-UHFFFAOYSA-N di-tert-butyl peroxide Chemical compound CC(C)(C)OOC(C)(C)C LSXWFXONGKSEMY-UHFFFAOYSA-N 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- XNMQEEKYCVKGBD-UHFFFAOYSA-N dimethylacetylene Natural products CC#CC XNMQEEKYCVKGBD-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010556 emulsion polymerization method Methods 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003759 ester based solvent Substances 0.000 description 1
- NHOGGUYTANYCGQ-UHFFFAOYSA-N ethenoxybenzene Chemical compound C=COC1=CC=CC=C1 NHOGGUYTANYCGQ-UHFFFAOYSA-N 0.000 description 1
- MEGHWIAOTJPCHQ-UHFFFAOYSA-N ethenyl butanoate Chemical compound CCCC(=O)OC=C MEGHWIAOTJPCHQ-UHFFFAOYSA-N 0.000 description 1
- GLVVKKSPKXTQRB-UHFFFAOYSA-N ethenyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC=C GLVVKKSPKXTQRB-UHFFFAOYSA-N 0.000 description 1
- UJRIYYLGNDXVTA-UHFFFAOYSA-N ethenyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC=C UJRIYYLGNDXVTA-UHFFFAOYSA-N 0.000 description 1
- AFSIMBWBBOJPJG-UHFFFAOYSA-N ethenyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC=C AFSIMBWBBOJPJG-UHFFFAOYSA-N 0.000 description 1
- UIWXSTHGICQLQT-UHFFFAOYSA-N ethenyl propanoate Chemical compound CCC(=O)OC=C UIWXSTHGICQLQT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 229940015043 glyoxal Drugs 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 229940042795 hydrazides for tuberculosis treatment Drugs 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- LDHQCZJRKDOVOX-IHWYPQMZSA-N isocrotonic acid Chemical compound C\C=C/C(O)=O LDHQCZJRKDOVOX-IHWYPQMZSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- GDOPTJXRTPNYNR-UHFFFAOYSA-N methyl-cyclopentane Natural products CC1CCCC1 GDOPTJXRTPNYNR-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- YCBSHDKATAPNIA-UHFFFAOYSA-N non-3-ene Chemical compound CCCCCC=CCC YCBSHDKATAPNIA-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- SFBTTWXNCQVIEC-UHFFFAOYSA-N o-Vinylanisole Chemical compound COC1=CC=CC=C1C=C SFBTTWXNCQVIEC-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000010815 organic waste Substances 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001254 oxidized starch Substances 0.000 description 1
- 235000013808 oxidized starch Nutrition 0.000 description 1
- UCUUFSAXZMGPGH-UHFFFAOYSA-N penta-1,4-dien-3-one Chemical compound C=CC(=O)C=C UCUUFSAXZMGPGH-UHFFFAOYSA-N 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010558 suspension polymerization method Methods 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- UIERETOOQGIECD-ONEGZZNKSA-N tiglic acid Chemical compound C\C=C(/C)C(O)=O UIERETOOQGIECD-ONEGZZNKSA-N 0.000 description 1
- WXBXVVIUZANZAU-CMDGGOBGSA-N trans-2-decenoic acid Chemical compound CCCCCCC\C=C\C(O)=O WXBXVVIUZANZAU-CMDGGOBGSA-N 0.000 description 1
- YIYBQIKDCADOSF-ONEGZZNKSA-N trans-pent-2-enoic acid Chemical compound CC\C=C\C(O)=O YIYBQIKDCADOSF-ONEGZZNKSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- External Artificial Organs (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は尿素吸着剤に関し、特に人工腎臓に有
用な新規高分子尿素吸着剤に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a urea adsorbent, and particularly to a novel polymeric urea adsorbent useful for artificial kidneys.
現在、人工腎臓として用いられているものとし
ては、透析型、ろ過型、吸着型及び酵素固定型人
工腎臓が挙げられる。
Artificial kidneys currently in use include dialysis-type, filtration-type, adsorption-type, and enzyme-immobilized artificial kidneys.
しかしながら、これらはいずれも一長一短を有
しており、慢性、急性腎不全患者に対して満足の
できるものは開発されていない。 However, all of these have advantages and disadvantages, and no drug has been developed that is satisfactory for patients with chronic or acute renal failure.
例えば透析型人工腎臓は、現在最も普及されて
いるものであるが、常に新しい透析液が必要とな
る。又、一般にこのものは装置が大型で腎不全患
者が長時間病院内に拘束されるという不便さが生
じる。 For example, dialysis-type artificial kidneys are currently the most popular, but new dialysate is always required. In addition, these devices are generally large in size, resulting in the inconvenience that renal failure patients are confined in the hospital for long periods of time.
ろ過型人工腎臓では、有用な成分を含む血清を
も廃棄してしまうという大きな欠点を有してい
る。 Filtration-type artificial kidneys have a major drawback in that serum containing useful components is also discarded.
酵素固定型人工腎臓は、最近、特に開発が進ん
でいるものであるが、ウレアーゼ固定時又は固定
後の酵素活性の失活が問題であり、又、その性能
も温度、酸性度等の周囲の環境に影響されやす
い。 Enzyme-immobilized artificial kidneys have been in particular progress in development recently, but there is a problem with the inactivation of the enzyme activity during or after urease immobilization, and its performance also depends on the surrounding environment such as temperature and acidity. Easily influenced by the environment.
吸着型人工腎臓は小型軽量で簡便なものである
が、吸着剤として活性炭が用いられており、有機
性老廃物には有効であるが、尿中に排泄される最
大成分である尿素には全く効力が無い。現在、吸
着型人工腎臓においては、尿素除去物質の探索が
最も重要な課題になつている。例えば酸化デンプ
ンの応用(高分子論文集、第39巻、第629頁)、ヒ
ドラジド基を有する重合体にホルムアルデヒド又
はグリオキザールを反応させてなる尿素吸着剤
(特開昭51−69489号公報)等が挙げられるが、実
用の段階には達していないのが実情である。 Adsorption-type artificial kidneys are small, lightweight, and simple, but they use activated carbon as an adsorbent, and although they are effective for organic wastes, they are completely ineffective against urea, which is the largest component excreted in urine. It has no effect. Currently, the search for urea removal substances is the most important issue in adsorption artificial kidneys. For example, there are applications of oxidized starch (Kobunshi Ronshu, Vol. 39, p. 629), urea adsorbents made by reacting formaldehyde or glyoxal with a polymer having a hydrazide group (Japanese Patent Application Laid-open No. 1983-69489), etc. However, the reality is that it has not yet reached the stage of practical use.
本発明者は前記の問題点を解決すべく高性能尿
所吸着剤について鋭意検討した結果、尿素除去物
質としてカルボキシル基とイミダゾール基の両基
を含む重合体が有用であり、更にポリオキシアル
キレングリコール誘導体を構成成分として含む重
合体がより一層の尿素吸着能を有する事実を見出
し、本発明に至つたのである。すなわち本発明
は、
(1) カルボキシル基と一般式(1)で示されるイミダ
ゾール基
(式中、R1は水素または炭素数5以下の炭化
水素基を表す。)
を構成成分として含有し、必要に応じて架橋剤
により架橋したエチレン性不飽和単量体の重合
体であつて、カルボキシル基の数とイミダゾー
ル基の数との比(カルボキシル基/イミダゾー
ル基)が、0.1乃至8.0であることを特徴とする
高分子尿素吸着剤。
As a result of intensive studies on high-performance urinary adsorbents to solve the above-mentioned problems, the present inventor found that a polymer containing both carboxyl groups and imidazole groups is useful as a urea removal substance, and polyoxyalkylene glycol The inventors discovered that a polymer containing a derivative as a constituent component has a higher urea adsorption ability, leading to the present invention. That is, the present invention provides: (1) a carboxyl group and an imidazole group represented by general formula (1); (In the formula, R 1 represents hydrogen or a hydrocarbon group having 5 or less carbon atoms.) A polymer of ethylenically unsaturated monomers that contains as a constituent component and is crosslinked with a crosslinking agent as necessary. , a polymer urea adsorbent characterized in that the ratio of the number of carboxyl groups to the number of imidazole groups (carboxyl group/imidazole group) is from 0.1 to 8.0.
(2)カルボキシル基、
一般式(1)で示されるイミダゾール基
(式中、R1は水素または炭素数5以下の炭化水
素基を表す。)、及び
一般式(2)
〔−(CH2−)oO−〕nR2 (2)
(式中nは2乃至5の整数、mは3以上の整数を
表し、R2は水素またはメチル基を表す。)で示さ
れるポリオキシアルキレングリコール誘導体基を
構成成分として含有し、必要に応じて架橋剤によ
り架橋したエチレン性不飽和単量体の重合体であ
つて、カルボキシル基とイミダゾール基の数との
比(カルボキシル基/イミダゾール基)が、0.1
乃至8.0であることを特徴とする高分子尿素吸着
剤に関する。(2) Carboxyl group, imidazole group represented by general formula (1) (In the formula, R 1 represents hydrogen or a hydrocarbon group having 5 or less carbon atoms.), and General formula (2) [-(CH 2 -) o O-] n R 2 (2) (In the formula, n is Contains a polyoxyalkylene glycol derivative group represented by an integer of 2 to 5, m represents an integer of 3 or more, and R2 represents hydrogen or a methyl group as a constituent component, and can be crosslinked with a crosslinking agent as necessary. A polymer of ethylenically unsaturated monomers having a ratio of the number of carboxyl groups to imidazole groups (carboxyl group/imidazole group) of 0.1.
The present invention relates to a polymer urea adsorbent characterized in that it has a molecular weight of 8.0 to 8.0.
本発明の尿素吸着剤は以下の方法により容易に
製造できる。即ち、カルボキシル基を有するエチ
レン性不飽和単量体もしくはカルボキシル基に変
換可能な基を有するエチレン性不飽和単量体と一
般式(1)に示すイミダゾール基を有するエチレン性
不飽和単量体をある一定のモル比で混合し、又は
さらに他のエチレン性不飽和単量体を追加し、ラ
ジカル重合法により製造される。その製造法は任
意であり、特に限定されるものではなく、塊状重
合法、溶液重合法、乳化重合法、懸濁重合法いず
れの方法においても製造することができる。 The urea adsorbent of the present invention can be easily produced by the following method. That is, an ethylenically unsaturated monomer having a carboxyl group or a group convertible to a carboxyl group and an ethylenically unsaturated monomer having an imidazole group shown in general formula (1). It is produced by radical polymerization by mixing at a certain molar ratio or by adding other ethylenically unsaturated monomers. The manufacturing method is arbitrary and is not particularly limited, and it can be manufactured by any of the bulk polymerization method, solution polymerization method, emulsion polymerization method, and suspension polymerization method.
カルボキシル基を有するエチレン性不飽和単量
体としては、具体的にアクリル酸、メタクリル
酸、クロトン酸、イソクロトン酸、2−ペンテン
酸、2−エチルアクリル酸、アンジエリカ酸、チ
グリン酸、3,3−ジメチルアクリル酸、3−プ
ロピルアクリル酸、3−イソプロピルアクリル
酸、トリメチルアクリル酸、2−ブチルアクリル
酸、3−ブチルアクリル酸、2−メチル−2−ヘ
キセン酸、2,3−ジエチルアクリル酸、2−オ
クテン酸、2−ノネン酸、2−デセン酸、α−ア
セトキシアクリル酸等のアクリル系不飽和単量
体、o−ビニル安息香酸、p−ビニル安息香酸、
3−ビニルサリチル酸、4−ビニルサリチル酸、
5−ビニルサリチル酸、3−ビニルアセチルサリ
チル酸、4−ビニルアセチルサリチル酸、5−ビ
ニルアセチルサリチル酸等のスチレン系不飽和単
量体、マレイン酸、メチルマレイン酸、ジメチル
マレイン酸、フエニルマレイン酸等の二官能性不
飽和単量体等をあげることができ、一種もしくは
二種以上のものを組み合せて使用することができ
る。 Examples of the ethylenically unsaturated monomer having a carboxyl group include acrylic acid, methacrylic acid, crotonic acid, isocrotonic acid, 2-pentenoic acid, 2-ethyl acrylic acid, andieric acid, tiglic acid, 3,3- Dimethyl acrylic acid, 3-propylacrylic acid, 3-isopropylacrylic acid, trimethylacrylic acid, 2-butylacrylic acid, 3-butylacrylic acid, 2-methyl-2-hexenoic acid, 2,3-diethylacrylic acid, 2 - Acrylic unsaturated monomers such as octenoic acid, 2-nonenoic acid, 2-decenoic acid, α-acetoxyacrylic acid, o-vinylbenzoic acid, p-vinylbenzoic acid,
3-vinylsalicylic acid, 4-vinylsalicylic acid,
Styrenic unsaturated monomers such as 5-vinylsalicylic acid, 3-vinylacetylsalicylic acid, 4-vinylacetylsalicylic acid, and 5-vinylacetylsalicylic acid; Examples include functional unsaturated monomers, which can be used singly or in combination of two or more.
カルボキシル基に変換可能な基を有するエチレ
ン性不飽和単量体とは、上記カルボキシル基を含
むエチレン性不飽和単量体の酸ハロゲン化物、酸
無水物、アルキルエステル化物、酸アミド化物、
酸イミド化物、酸ヒドラジド化物、酸無機塩等や
α−アンジエリカラクトン、α−メチレン−γ−
ブチロラクトン、2(5H)−フラノン等の不飽和
ラクトン、アクリロニトリル、メタクリロニトリ
ル等の不飽和ニトリル等も使用することができ、
重合後いずれも加水分解処理によりカルボキシル
基に変換することが可能である。又、重合後酸化
反応によりカルボキシル基を導入することも可能
であるが、主鎖の切断やイミダゾール基の開環反
応等の好ましくない副反応が引き起されるため、
本発明においては好ましくない。 Ethylenically unsaturated monomers having a group convertible to a carboxyl group include acid halides, acid anhydrides, alkyl esters, acid amides,
Acid imidides, acid hydrazides, acid inorganic salts, α-angiericalactone, α-methylene-γ-
Unsaturated lactones such as butyrolactone and 2(5H)-furanone, unsaturated nitriles such as acrylonitrile and methacrylonitrile, etc. can also be used.
After polymerization, any of them can be converted into carboxyl groups by hydrolysis treatment. It is also possible to introduce a carboxyl group by an oxidation reaction after polymerization, but this causes undesirable side reactions such as cleavage of the main chain and ring-opening reaction of the imidazole group.
This is not preferred in the present invention.
イミダゾール基を有するエチレン性不飽和単量
体とは、例えば1−ビニルイミダゾール、2−ビ
ニルイミダゾール、4−ビニルイミダゾール、1
−メチル−2−ビニルイミダゾール、1−メチル
−5−ビニルイミダゾール、1−エチル−5−ビ
ニルイミダゾール、1−プロピル−5−ビニルイ
ミダゾール、1−ブチル−5−ビニルイミダゾー
ル等をあげることができ、一種もしくは二種以上
のものを組み合せて使用することができる。 The ethylenically unsaturated monomer having an imidazole group is, for example, 1-vinylimidazole, 2-vinylimidazole, 4-vinylimidazole, 1
-Methyl-2-vinylimidazole, 1-methyl-5-vinylimidazole, 1-ethyl-5-vinylimidazole, 1-propyl-5-vinylimidazole, 1-butyl-5-vinylimidazole, etc. One type or a combination of two or more types can be used.
カルボキシル基を有するエチレン性不飽和単量
体もしくはカルボキシル基に変換可能な基を有す
るエチレン性不飽和単量体と、イミダゾール基を
有するエチレン性不飽和単量体とからまずアシル
イミダゾールを合成し、このものを重合し、重合
後加水分解することにより、遊離のカルボキシル
基とイミダゾール基に変換する方法も有効であり
使用することができる。 First, an acylimidazole is synthesized from an ethylenically unsaturated monomer having a carboxyl group or an ethylenically unsaturated monomer having a group convertible to a carboxyl group, and an ethylenically unsaturated monomer having an imidazole group, A method of converting this product into free carboxyl groups and imidazole groups by polymerizing it and hydrolyzing it after the polymerization is also effective and can be used.
本発明においては、他のエチレン性不飽和単量
体をも必要に応じて重合体の製造に使用すること
ができ、これらはたとえカルボン酸誘導体であつ
ても、重合後カルボキシル基に変換する必要のな
いものであつて、例えば、エチレン、プロピレ
ン、1−ブテン、2−ブテン、1−ヘキセン、2
−エチル−1−ブテン、1−メチルシクロペンテ
ン、1−ヘプテン、2−ヘプテン、2−メチル−
1−ヘキセン、シクロヘプテン、1−オクテン、
2−オクテン、1−ノネン、1−ブテン、2−ノ
ネン、3−ノネン、1−フエニル−2−ペンテ
ン、α−ピネン、β−ピネン等のオレフイン系不
飽和単量体、クロロエチレン、プロモエチレン、
1,1−ジクロロエチレン、1,2−ジクロロエ
チレン、トリフルオロエチレン等のハロゲン化エ
チレン系不飽和単量体、スチレン、o−メチルス
チレン、m−メチルスチレン、p−メチルスチレ
ン、o−エチルスチレン、m−エチルスチレ、p
−エチルスチレン、o−クロロスチレン、m−ク
ロロスチレン、p−クロロスチレン、m−クロロ
メチルスチレン、p−クロロメチルスチレン、o
−メトキシスチレン、m−メトキシスチレン、p
−メトキシスチレン、o−ニトロスチレン、m−
ニトロスチレン、p−ニトロスチレン、o−シア
ノスチレン、m−シアノスチレン、p−シアノス
チレン等のスチレン系不飽和単量体、メチルビニ
ルエーテル、エチルビニルエーテル、n−プロピ
ルビニルエーテル、i−プロピルビニルエーテ
ル、n−ブチルビニルエーテル、sec−ブチルビ
ニルエーテル、t−ブチルビニルエーテル、フエ
ニルビニルエーテル等のビニルエーテル系不飽和
単量体、メチルビニルケトン、アセトキシビニル
ケトン、エチルビニルケトン、n−プロピルビニ
ルケトン、i−プロピルビニルケトン、フエニル
ビニルケトン等のビニルケトン系不飽和単量体、
酢酸ビニル、エトキシ酢酸ビニル、プロピオン酸
ビニル、酪酸ビニル、ラウリル酸ビニル、パルミ
チン酸ビニル、ステアリン酸ビニル等のビニルエ
ステル系不飽和単量体、(メタ)アクリル酸メチ
ル、(メタ)アクリル酸エチル、(メタ)アクリル
酸−n−プロピル、(メタ)アクリル酸n−ブチ
ル、(メタ)アクリル酸n−アミル、(メタ)アク
リル酸n−ヘキシル、(メタ)アクリル酸オクチ
ル、(メタ)アクリル酸ノニル、(メタ)アクリル
酸デシル、(メタ)アクリル酸ドデシル、(メタ)
アクリル酸オレイル、(メタ)アクリル酸グリシ
ジル等の(メタ)アクリル酸エステル系単量体、
その他、無水マレイン酸、アクリルニトリル、ア
クリルアミド等の単量体を必要に応じて使用する
ことができ、これらの一種もしくは二種以上を使
用することができる。 In the present invention, other ethylenically unsaturated monomers can also be used in the production of the polymer if necessary, and even if they are carboxylic acid derivatives, they need to be converted into carboxyl groups after polymerization. For example, ethylene, propylene, 1-butene, 2-butene, 1-hexene, 2
-ethyl-1-butene, 1-methylcyclopentene, 1-heptene, 2-heptene, 2-methyl-
1-hexene, cycloheptene, 1-octene,
Olefinic unsaturated monomers such as 2-octene, 1-nonene, 1-butene, 2-nonene, 3-nonene, 1-phenyl-2-pentene, α-pinene, β-pinene, chloroethylene, promoethylene ,
Halogenated ethylenically unsaturated monomers such as 1,1-dichloroethylene, 1,2-dichloroethylene, trifluoroethylene, styrene, o-methylstyrene, m-methylstyrene, p-methylstyrene, o-ethylstyrene, m -ethyl styrene, p
-ethylstyrene, o-chlorostyrene, m-chlorostyrene, p-chlorostyrene, m-chloromethylstyrene, p-chloromethylstyrene, o
-methoxystyrene, m-methoxystyrene, p
-methoxystyrene, o-nitrostyrene, m-
Styrenic unsaturated monomers such as nitrostyrene, p-nitrostyrene, o-cyanostyrene, m-cyanostyrene, p-cyanostyrene, methyl vinyl ether, ethyl vinyl ether, n-propyl vinyl ether, i-propyl vinyl ether, n- Vinyl ether unsaturated monomers such as butyl vinyl ether, sec-butyl vinyl ether, t-butyl vinyl ether, phenyl vinyl ether, methyl vinyl ketone, acetoxy vinyl ketone, ethyl vinyl ketone, n-propyl vinyl ketone, i-propyl vinyl ketone, Vinyl ketone unsaturated monomers such as phenyl vinyl ketone,
Vinyl ester unsaturated monomers such as vinyl acetate, ethoxyvinyl acetate, vinyl propionate, vinyl butyrate, vinyl laurate, vinyl palmitate, vinyl stearate, methyl (meth)acrylate, ethyl (meth)acrylate, n-propyl (meth)acrylate, n-butyl (meth)acrylate, n-amyl (meth)acrylate, n-hexyl (meth)acrylate, octyl (meth)acrylate, nonyl (meth)acrylate , (meth)decyl acrylate, (meth)dodecyl acrylate, (meth)
(meth)acrylic acid ester monomers such as oleyl acrylate and glycidyl (meth)acrylate;
In addition, monomers such as maleic anhydride, acrylonitrile, and acrylamide can be used as required, and one or more of these monomers can be used.
特に、他のエチレン性不飽和単量体として、一
般式(3)又は(4)
(式中、nは2乃至5の整数、mは3以上の整数
であり、R3は水素もしくはメチル基、R4は水素
もしくは炭素数1乃至10の炭化水素基を示す。)
で示されるラジカル重合性ポリオキシアルキレン
グリコール誘導体を重合体の製造に用いると、一
般式(2)で示されるポリオキシアルキレングリコー
ル誘導体基を構成成分として含む重合体を得るこ
とができる。 In particular, as other ethylenically unsaturated monomers, general formula (3) or (4) (In the formula, n is an integer of 2 to 5, m is an integer of 3 or more, R 3 is hydrogen or a methyl group, and R 4 is hydrogen or a hydrocarbon group having 1 to 10 carbon atoms.) When a radically polymerizable polyoxyalkylene glycol derivative is used in the production of a polymer, a polymer containing a polyoxyalkylene glycol derivative group represented by general formula (2) as a constituent component can be obtained.
本発明で用いられる一般式(3)で示されるラジカ
ル重合性ポリオキシアルキレングリコール誘導体
は、例えばポリオキシエチレングリコールモノ
(メタ)アクリレート、ポリオキシトリメチレン
グリコール(メタ)アクリレート、ポリオキシテ
トラメチレングリコールモノ(メタ)アクリレー
ト、ω−メトキシポリオキシエチレングリコール
モノ(メタ)アクリレート、ω−メトキシポリオ
キシトリメチレングリコールモノ(メタ)アクリ
レート、ω−メトキシポリオキシテトラメチレン
グリコールモノ(メタ)アクリレートであり、又
一般式(4)で示されるラジカル重合性ポリオキシア
ルキレングリコール誘導体は、例えばα−(p−
ビニルベンジロキシ)−ポリオキシエチレングリ
コール、α−(p−ビニルベンジロキシ)−ポリオ
キシトリメチレングリコール、α−(p−ビニル
ベンジロキシ)−ポリテトラメチレングリコール、
α−(p−ビニルベンジロキシ)−ω−メトキシポ
リオキシエチレングリコール、α−(p−ビニル
ベンジロキシ)−ω−メトキシポリオキシトリメ
チレングリコール、α−(p−ビニルベンジロキ
シ)−ω−メトキシポリオキシテトラメチレング
リコールである。 The radically polymerizable polyoxyalkylene glycol derivative represented by the general formula (3) used in the present invention is, for example, polyoxyethylene glycol mono(meth)acrylate, polyoxytrimethylene glycol (meth)acrylate, polyoxytetramethylene glycol mono (meth)acrylate, ω-methoxypolyoxyethylene glycol mono(meth)acrylate, ω-methoxypolyoxytrimethylene glycol mono(meth)acrylate, ω-methoxypolyoxytetramethylene glycol mono(meth)acrylate, and general The radically polymerizable polyoxyalkylene glycol derivative represented by formula (4) is, for example, α-(p-
vinylbenzyloxy)-polyoxyethylene glycol, α-(p-vinylbenzyloxy)-polyoxytrimethylene glycol, α-(p-vinylbenzyloxy)-polytetramethylene glycol,
α-(p-vinylbenzyloxy)-ω-methoxypolyoxyethylene glycol, α-(p-vinylbenzyloxy)-ω-methoxypolyoxytrimethylene glycol, α-(p-vinylbenzyloxy)-ω-methoxy It is polyoxytetramethylene glycol.
一般式(3)もしくは(4)で示されるラジカル重合性
ポリオキシアルキレングリコール誘導体は、他の
エチレン性不飽和単量体と同時に使用することが
でき、必要に応じて一種もしくは二種以上のもの
を用いることができる。 The radically polymerizable polyoxyalkylene glycol derivative represented by general formula (3) or (4) can be used simultaneously with other ethylenically unsaturated monomers, and if necessary, one or more types can be used. can be used.
一般式(2)で示されるポリオキシアルキレングリ
コール誘導体を構成成分として本発明における尿
素吸着剤に導入することにより、カルボキシル
基、イミダゾール基との相乗効果により、更に一
層尿素吸着能を発揮させることができる。本発明
に用いられる一般式(3)もしくは(4)で示されるラジ
カル重合性ポリオキシアルキレングリコール誘導
体の数平均分子量は120以上であるが、好ましく
は200以上であり、これよりも小さいと、その相
乗効果は期待できない。 By introducing the polyoxyalkylene glycol derivative represented by the general formula (2) into the urea adsorbent of the present invention as a constituent component, it is possible to further exhibit urea adsorption ability due to the synergistic effect with the carboxyl group and imidazole group. can. The number average molecular weight of the radically polymerizable polyoxyalkylene glycol derivative represented by the general formula (3) or (4) used in the present invention is 120 or more, preferably 200 or more; No synergistic effects can be expected.
本発明における高分子尿素吸着剤の製造におい
て、必要に応じて架橋剤も使用できる。架橋剤と
しては例えばジビニルベンゼン、エチレングリコ
ール(メタ)アクリレート、ポリオキシエチレン
グリコール(メタ)アクリレート、ポリジメチル
シロキサンジ(メタ)アクリレート、ポリアミド
ジ(メタ)アクリレート等いずれも使用すること
が可能である。架橋剤の使用量は、全重量に対し
て0.01重量%乃至50重量%であり、それよりも多
くなると、製造された尿素吸着剤の水に対する潤
滑度が著しく低くなり好ましくない。又、本発明
の尿素吸着剤は対して不溶であることが絶対条件
であり、そのために水に可溶である重合体の場合
には、架橋剤を使用して不溶にする必要がある。
叉、架橋剤を用い無い場合でも他のエチレン性不
飽和単量体の量を増すことにより不溶化すること
ができ、特にオレフイン系不飽和単量体、スチレ
ン系不飽和単量体が効果的である。 In the production of the polymeric urea adsorbent in the present invention, a crosslinking agent can also be used if necessary. As the crosslinking agent, for example, divinylbenzene, ethylene glycol (meth)acrylate, polyoxyethylene glycol (meth)acrylate, polydimethylsiloxane di(meth)acrylate, polyamide di(meth)acrylate, etc. can be used. The amount of the crosslinking agent to be used is 0.01% to 50% by weight based on the total weight, and if it is more than that, the lubricity of the produced urea adsorbent with respect to water will be significantly lowered, which is not preferable. Moreover, it is an absolute condition that the urea adsorbent of the present invention is insoluble in water, and therefore, in the case of a polymer that is soluble in water, it is necessary to use a crosslinking agent to make it insoluble.
Furthermore, even if a crosslinking agent is not used, insolubilization can be achieved by increasing the amount of other ethylenically unsaturated monomers, and olefinic unsaturated monomers and styrenic unsaturated monomers are particularly effective. be.
本発明の尿素吸着剤の製造例を示す。例えば、
溶液重合法の例を示すと、それぞれ等モルのメチ
ルメタクリレート、1−ビニルイミダゾール、ア
クリル酸、ポリオキシエチレングリコールモノメ
タアクリレート、及び1/10モル等量のエチレン
グリコールジメタクリレートを溶剤に溶解し、重
合開始剤を使用して窒素気流下でかきまぜを行い
重合せしめる。重合終了後、混合物を水に流し込
み重合体を沈澱させ、洗浄、乾燥、粉砕を実施し
高分子尿素接着剤を調整することができる。該高
分子尿素吸着剤の構造は、カルボキシル基とイミ
ダゾール基の比は仕込み比から1と考えられ、又
一般式(2)で示された構成成分は、全重量の58重量
%であり、良好な尿素吸着機能を示す。本発明に
おいては、カルボキシル基を有するエチレン性不
飽和単量体もしくはカルボキシル基に変換可能な
基を有するエチレン性不飽和単量体の仕込み量、
及びイミダゾール基を有するエチレン性不飽和単
量体の仕込み量はそれぞれ全仕込み量の5重量%
以上必要であり、いずれか一方がそれ以下の場合
には尿素吸着能は乏しく有効でない。 An example of manufacturing the urea adsorbent of the present invention will be shown. for example,
An example of the solution polymerization method is to dissolve equimolar amounts of methyl methacrylate, 1-vinylimidazole, acrylic acid, polyoxyethylene glycol monomethacrylate, and 1/10 molar equivalent of ethylene glycol dimethacrylate in a solvent, Polymerization is carried out using a polymerization initiator and stirring under a nitrogen stream. After the polymerization is completed, the mixture is poured into water to precipitate the polymer, followed by washing, drying, and pulverization to prepare a polymeric urea adhesive. The structure of the polymeric urea adsorbent is considered to be good, as the ratio of carboxyl groups to imidazole groups is considered to be 1 from the charging ratio, and the component represented by general formula (2) is 58% by weight of the total weight. It shows excellent urea adsorption function. In the present invention, the charged amount of an ethylenically unsaturated monomer having a carboxyl group or an ethylenically unsaturated monomer having a group convertible to a carboxyl group,
The charged amount of ethylenically unsaturated monomer having an imidazole group is 5% by weight of the total charged amount, respectively.
If either one is less than this, the urea adsorption ability is poor and is not effective.
本発明における吸着剤に含まれるカルボキシル
基の数とイミダゾール基の数の比はr1=(カルボ
キシル基の数)/(イミダゾール基の数)とする
と、r1=0.1乃至8であり、好ましくr1=2乃至
0.5であり、最も好ましくはr1=1である。 The ratio of the number of carboxyl groups to the number of imidazole groups contained in the adsorbent in the present invention is r 1 =(number of carboxyl groups)/(number of imidazole groups), and is preferably r 1 =0.1 to 8. 1 = 2 to
0.5 and most preferably r 1 =1.
r1=1の時に本発明における尿素吸着剤は、最
も有効な尿素吸着能を示す。 When r 1 =1, the urea adsorbent of the present invention exhibits the most effective urea adsorption ability.
r1が0.1より小さい場合にも、8より大きい場
合にも尿素吸着能は激滅する。 The urea adsorption capacity decreases both when r 1 is smaller than 0.1 and when it is larger than 8.
このものに一般式(2)で示される構成成分を導入
することにより、更に一層尿素吸着能を改良する
ことが可能となる。そのためには、一般式(2)で示
される構成成分は全重量の2重量%以上70重量%
以下である。2重量%以下であるとその効果は期
待できない。 By introducing the component represented by general formula (2) into this product, it becomes possible to further improve the urea adsorption ability. For this purpose, the component represented by general formula (2) must be at least 2% by weight or more than 70% by weight of the total weight.
It is as follows. If it is less than 2% by weight, the effect cannot be expected.
又、70重量%以上となる、製造された尿素吸着
剤の吸水性が増大し、取り扱いに不便さを生じ
る。 Moreover, the water absorption of the produced urea adsorbent increases to 70% by weight or more, causing inconvenience in handling.
該尿素吸着剤を製造するにあたつて重合開始剤
が使用されるが、特に限定されることなく、アゾ
化合物、過酸化物、レドツクス系開始剤等のいず
れも使用することができる。例えば、アゾ化合物
としては、α,α′−アゾビスイソブチロニトリ
ル、2,2′−アゾビス−(2,4−ジメチルバレ
ロニトリル)等があげられ、過酸化物としては、
ジベンゾイルペルオキシド、ラウロイルペルオキ
シド、ジ−t−ブチルペルオキシド、ジクミルペ
ルオキシド、t−ブチルハイドロペルオキシド、
ジイソプロピルペルオキシドカーボネイト等があ
げられ、レドツクス開始剤としては、過酸化水素
−Fe2+塩、過硫酸塩−亜硫酸水素ナトリウム、
クメンヒドロペルオキシド−Fe2+塩、過酸化ベ
ンゾイル−ジメチルアニリン等があげられる。 A polymerization initiator is used in producing the urea adsorbent, but there is no particular limitation, and any of azo compounds, peroxides, redox initiators, etc. can be used. For example, azo compounds include α,α'-azobisisobutyronitrile, 2,2'-azobis-(2,4-dimethylvaleronitrile), and peroxides include:
dibenzoyl peroxide, lauroyl peroxide, di-t-butyl peroxide, dicumyl peroxide, t-butyl hydroperoxide,
Examples include diisopropyl peroxide carbonate, and redox initiators include hydrogen peroxide-Fe 2+ salt, persulfate-sodium bisulfite,
Examples include cumene hydroperoxide-Fe 2+ salt, benzoyl peroxide-dimethylaniline, and the like.
溶液重合法において用いられる溶剤は、単量体
が溶解し得るものであり、重合を阻害しないもの
であれば何ら限定されることはなく、例えばN,
N′−ジメチルホルムアミド、N,N′−ジメチル
アセトアミド等のアミド系溶剤、ベンゼン、トル
エン、キシレン等の芳香族系炭化水素、酢酸メチ
ル、酢酸エチル、酢酸プロピル、酢酸ブチル等の
エステル系溶剤、メタノール、エタノール、イソ
プロピルアルコール、n−プロピルアルコール、
n−ブタノール、イソブタノール、sec−ブタノ
ール、t−ブタノール等のアルコール系溶剤、ア
セトン、メチルエチルケトン、ジエチルケトン等
のケトン系溶剤が使用される。 The solvent used in the solution polymerization method is not limited in any way as long as it can dissolve the monomer and does not inhibit polymerization, such as N,
Amide solvents such as N'-dimethylformamide and N,N'-dimethylacetamide, aromatic hydrocarbons such as benzene, toluene and xylene, ester solvents such as methyl acetate, ethyl acetate, propyl acetate and butyl acetate, methanol , ethanol, isopropyl alcohol, n-propyl alcohol,
Alcohol solvents such as n-butanol, isobutanol, sec-butanol and t-butanol, and ketone solvents such as acetone, methyl ethyl ketone and diethyl ketone are used.
球状の重合体粒子を得るためには、懸濁重合法
もしくは乳化重合法を採用することもでき、これ
らの場合には水を溶剤とし、分散安定剤や界面活
性剤を用いて重合せしめることが可能である。
(特開昭60−55009号公報、特願昭171760号公報)
本発明の吸着剤の重合体の分子量は、3000乃至
100万、好ましくは5000乃至10万である。 In order to obtain spherical polymer particles, suspension polymerization or emulsion polymerization can be used. In these cases, polymerization can be carried out using water as a solvent and a dispersion stabilizer or surfactant. It is possible.
(Japanese Unexamined Patent Publication No. 1983-55009, Japanese Patent Application No. 171760) The molecular weight of the polymer of the adsorbent of the present invention is 3000 to 3000.
1 million, preferably 5,000 to 100,000.
以上のようにして製造された尿素吸着剤は、そ
のまま吸着剤として使用することが可能であり、
叉必要に応じて表面の改質反応を実施したり、ヘ
パリンやアルブミンのコーテイング、プラズマ処
理等の処理後尿素吸着剤として使用してもよい。 The urea adsorbent produced as described above can be used as an adsorbent as is,
If necessary, it may be used as a urea adsorbent after carrying out a surface modification reaction, coating with heparin or albumin, plasma treatment, or the like.
本発明における高分子尿素吸着剤は、高性能の
尿素吸着能を有しており(100mg/dl、尿素水溶
液50mlに0.5gの該尿素吸着剤を入れ、2時間浸
漬せしめることにより尿素濃度を25mg/dlにまで
減少させることが可能である。)、吸着型人工腎臓
やセンサーに応用可能である。
The polymer urea adsorbent of the present invention has a high urea adsorption capacity (100 mg/dl), and by adding 0.5 g of the urea adsorbent to 50 ml of urea aqueous solution and soaking it for 2 hours, the urea concentration can be reduced to 25 mg. /dl), which can be applied to adsorption-type artificial kidneys and sensors.
以下、実施例により本発明を具体的に説明する
が、本発明はこれら実施例に限定されるものでは
ない。
EXAMPLES Hereinafter, the present invention will be specifically explained with reference to Examples, but the present invention is not limited to these Examples.
実施例 1
アクリル酸7.5g、1−ビニルイミダゾール9.4
g、エチレングリコールメタクリレート2g、
α,α′−アゾピスイソプチロニトリル(AIBN)
0.1gをN,N′−ジメチルホルムアルデヒド
(DMF)100mlに溶解し、窒素気流下110℃で2時
間重合せしめた。その後少量のAIBNを加え、減
圧加熱下でDMFを留去せしめ、重合反応を完結
させた。重合残留物を1の水の中に入れて室温
で1時間かきまぜた後、遠心分離機により重合物
を分離し、そのものを更に水で2回、メタノール
で2回、アセトンで1回洗浄を行い、減圧下50℃
で1日乾燥せしめた。乾燥後粉砕し、平均粒径約
100μの粒子を得た。該重合体の組成は赤外線吸
収スペクトルによりカルボキシル基(3300〜300
cm-1、1750cm-1)とイミダゾール基(1550、
1490、1325cm-1)の存在が確認され、その仕込み
量からカルボキシル基の数とイミダゾール基の数
の比が1と考えられる。カルボキシル基とイミダ
ゾール基は重合体内で弱い相互作用をするが、赤
外線吸収スペクトルの吸収域から考慮してランダ
ム状に配置されている。又、該重合体は架橋高分
子であり、あらゆる溶剤に不溶であるが、水に対
する膨潤度は良好である。Example 1 Acrylic acid 7.5g, 1-vinylimidazole 9.4g
g, 2 g of ethylene glycol methacrylate,
α,α′-Azopisisobutyronitrile (AIBN)
0.1 g was dissolved in 100 ml of N,N'-dimethylformaldehyde (DMF) and polymerized at 110° C. for 2 hours under a nitrogen stream. Thereafter, a small amount of AIBN was added, and DMF was distilled off under reduced pressure and heating to complete the polymerization reaction. The polymerization residue was placed in the water from step 1 and stirred at room temperature for 1 hour, and then the polymerization product was separated using a centrifuge, which was further washed twice with water, twice with methanol, and once with acetone. , 50℃ under reduced pressure
I let it dry for a day. After drying, grind to an average particle size of approx.
100μ particles were obtained. The composition of the polymer was determined by infrared absorption spectrum to show carboxyl groups (3300 to 300
cm -1 , 1750cm -1 ) and imidazole group (1550,
1490, 1325 cm -1 ) was confirmed, and the ratio of the number of carboxyl groups to the number of imidazole groups is considered to be 1 from the amount charged. The carboxyl groups and imidazole groups interact weakly within the polymer, but are arranged randomly in consideration of the absorption range of the infrared absorption spectrum. Further, the polymer is a crosslinked polymer and is insoluble in all solvents, but has a good degree of swelling in water.
該重合体粒子をそのまま尿素吸着剤として用
い、尿素吸着量を以下の如くにして測定した。 The polymer particles were used as they were as a urea adsorbent, and the amount of urea adsorbed was measured as follows.
100ml尿素/dlの水溶液50mlに該吸着剤を0.5g
入れ、20℃で2時間かきまぜを行つた。その後遠
心分離し、その上澄み液に対してジアセチル法に
より尿素の濃度を比色定量した。(日立製作所製
150−20型分光光度計を用い480nm比色定量し
た。)その結果、尿素濃度が30mg尿素/dlにまで
減少している事実が分かつた。比較までに該吸着
剤の代わりに活性炭を用いた場合には、95mg尿
素/dlにまでしか減少しなかつた。 0.5g of the adsorbent in 50ml of 100ml urea/dl aqueous solution
and stirred at 20°C for 2 hours. Thereafter, the mixture was centrifuged, and the concentration of urea in the supernatant was determined colorimetrically by the diacetyl method. (Manufactured by Hitachi, Ltd.
Colorimetric determination was carried out at 480 nm using a 150-20 spectrophotometer. ) As a result, it was found that the urea concentration had decreased to 30mg urea/dl. For comparison, when activated carbon was used instead of the adsorbent, the amount decreased to only 95 mg urea/dl.
このようにカルボキシル基の数とイミダゾール
基の数の比が1で存在し、その両者のみで構成さ
れている重合体は非常に高い尿素吸着機能を有し
ている事実が分かつた。 It has thus been found that the ratio of the number of carboxyl groups to the number of imidazole groups is 1, and that a polymer composed only of both has a very high urea adsorption function.
尚、本実施例において、赤外線吸収スペクトル
は日本分光(株)製A−102型 赤外分光光度計を、
紫外・可視吸収スペクトルは日立製作所(株)製150
−20型 紫外・可視分光光度計を用いて測定し
た。 In this example, the infrared absorption spectrum was measured using a model A-102 infrared spectrophotometer manufactured by JASCO Corporation.
Ultraviolet/visible absorption spectrum is 150 manufactured by Hitachi, Ltd.
Measurements were made using a -20 type ultraviolet/visible spectrophotometer.
実施例 2
1−ビニルイミダゾール10g、メタクリル酸ク
ロライド11.0gを50mlのトルエンに入れ、室温で
1時間かきまぜを行うと白色沈澱が生成した。こ
の白色沈澱はメタクリロイルイミダゾール塩であ
り、メタクリロイル基と1−ビニルイミダゾール
の1対1の塩である。該イミダゾール塩をろ過
し、100mlのDMFに溶解し、そのものに1gのジ
ビニルベンゼンと0.1gのAIBNを加え、110℃で
2時間重合を行つた。その後少量のAIBNを加
え、減圧加熱下DMFを留去せしめ、重合反応を
完結させた。重合残留物を1の水中に入れ室温
で5時間かきまぜた後、炭酸水素ナトリウムを二
酸化炭素が出なくなるまで加え中和した。この時
点でカルボキシル基とイミダゾール基が遊離さ
れ、赤外線吸収スペクトルによりカルボキシル基
とイミダゾール基の存在が確認された。以後、実
施例1と同様の方法で分離、精製、乾燥、粉枠を
行い尿素吸着剤を得た。該重合体はカルボキシル
基とイミダゾール基を含んでおり、その比は仕込
み比から1と考えられ、更にジビニルベンゼンに
より架橋された高分子体であり、あらゆる溶剤に
不溶であるが、水に対する膨潤度は良好である。
該吸着剤を用いて尿素吸着試験を実施した。その
結果、尿素濃度が30mg尿素/dlにまで減少してい
る事実が分かつた。このように、まずメタクリル
酸クロライドと1−ビニルイミダゾールから塩を
合成し重合を行つた場合の尿素吸着剤も非常に高
い尿素吸着能を有している事実が分かつた。Example 2 10 g of 1-vinylimidazole and 11.0 g of methacrylic acid chloride were added to 50 ml of toluene and stirred at room temperature for 1 hour to form a white precipitate. This white precipitate is a methacryloyl imidazole salt, which is a 1:1 salt of methacryloyl group and 1-vinylimidazole. The imidazole salt was filtered and dissolved in 100 ml of DMF, to which were added 1 g of divinylbenzene and 0.1 g of AIBN, and polymerization was carried out at 110° C. for 2 hours. Thereafter, a small amount of AIBN was added, and DMF was distilled off under reduced pressure and heating to complete the polymerization reaction. The polymerization residue was placed in water from Step 1 and stirred at room temperature for 5 hours, and then neutralized by adding sodium hydrogen carbonate until no carbon dioxide was released. At this point, the carboxyl group and imidazole group were liberated, and the presence of the carboxyl group and imidazole group was confirmed by infrared absorption spectrum. Thereafter, separation, purification, drying, and powder frame were performed in the same manner as in Example 1 to obtain a urea adsorbent. The polymer contains carboxyl groups and imidazole groups, and the ratio is thought to be 1 based on the charging ratio.It is also a polymer crosslinked with divinylbenzene, and is insoluble in all solvents, but has a high degree of swelling in water. is in good condition.
A urea adsorption test was conducted using the adsorbent. As a result, it was found that the urea concentration had decreased to 30 mg urea/dl. In this way, it has been found that a urea adsorbent obtained by first synthesizing a salt from methacrylic acid chloride and 1-vinylimidazole and then polymerizing it also has a very high urea adsorption capacity.
実施例 3
1−ビニルイミダゾール10g、アクリル酸7.9
g、ポリオキシエチレグリコールモノメタクリレ
ート(ブレンマーPE350、数平均分子量400、日
本油脂社製)20g、エチレングリコールジメタク
リレート2g、AIBN 0.1gをDMF100mlに溶解
し、実施例1と同法で尿素吸着剤を調整した。赤
外線吸収スペクトルにより該吸着剤にはカルボキ
シル基、イミダゾール基及び水酸基(3500〜3300
cm-1)が含まれていることが確認され、仕込み比
によりカルボキシル基とイミダゾール基の比が1
であり、ポリオキシエチレングリコール誘導体が
全重量の50重量%存在する重合体である。更に架
橋重合体であり、あらゆる溶剤に不溶であるが、
水に対する膨潤性は良好であり、実施例1のそれ
よりも優れている。該吸着剤を用いて実施例1と
同法で尿素吸着試験を実施したところ、25mg尿
素/dlにまで減少している事実が分かつた。この
ように、ポリオキシエチレングリコール誘導体が
含まれている場合には尿素吸着能が改良されるこ
とが分かる。Example 3 1-vinylimidazole 10g, acrylic acid 7.9g
g, 20 g of polyoxyethylene glycol monomethacrylate (Blenmar PE350, number average molecular weight 400, manufactured by NOF Corporation), 2 g of ethylene glycol dimethacrylate, and 0.1 g of AIBN were dissolved in 100 ml of DMF, and a urea adsorbent was added in the same manner as in Example 1. It was adjusted. According to the infrared absorption spectrum, the adsorbent contains carboxyl groups, imidazole groups, and hydroxyl groups (3500 to 3300
cm -1 ) was confirmed, and the ratio of carboxyl groups to imidazole groups was 1 depending on the preparation ratio.
It is a polymer in which the polyoxyethylene glycol derivative is present at 50% by weight of the total weight. Furthermore, it is a crosslinked polymer and is insoluble in all solvents, but
The water swelling property is good and better than that of Example 1. When a urea adsorption test was conducted using the adsorbent in the same manner as in Example 1, it was found that the adsorption amount was reduced to 25 mg urea/dl. Thus, it can be seen that when a polyoxyethylene glycol derivative is contained, the urea adsorption ability is improved.
実施例 4
メタアクリル酸2g、4−ビニルイミダゾール
2g、ポリオキシエチレングリコールモノメタク
リレート(ブレンマーPE350、数平均分子量400、
日本油脂社製)、4.2g、エチレングリコールジメ
タクリレート1.1g、AIBN 0.05gを100mlの
DMFに溶解し、実施例1と同様の方法で尿素吸
着剤を調整した。赤外線吸収スペクトルにより、
該吸着剤にはカルボキシル基、イミダゾール基、
及び水酸基が含まれていることが確認され、更に
遊離の−NH基(3210cmp-1、鋭い吸収)が存在
することが確認された。該重合体はその仕込み比
により、カルボキシル基とイミダゾール基の比が
1であり、ポリオキシエチレングリコール誘導体
が全重量の50重量%存在する重合体である。更
に、架橋重合体であり、あらゆる溶剤に不溶であ
るが、水に対する膨潤性は良好である。該吸着剤
を用いて実施例1と同様な方法で尿素吸着試験を
実施したところ、37mg尿素/dlにまで減少してい
る事実が分かつた。このように、イミダゾール基
を有する不飽和単量体として4−ビニルイミダゾ
ールを用いた場合でも、本発明における尿素吸収
剤は高い吸着能を示すことが分る。Example 4 2 g of methacrylic acid, 2 g of 4-vinylimidazole, polyoxyethylene glycol monomethacrylate (Blemmer PE350, number average molecular weight 400,
(manufactured by NOF Corporation), 4.2g, ethylene glycol dimethacrylate 1.1g, AIBN 0.05g in 100ml
A urea adsorbent was prepared by dissolving it in DMF and using the same method as in Example 1. By infrared absorption spectrum,
The adsorbent contains a carboxyl group, an imidazole group,
It was confirmed that hydroxyl groups and hydroxyl groups were contained, and it was further confirmed that a free -NH group (3210 cmp -1 , sharp absorption) was present. This polymer is a polymer in which the ratio of carboxyl groups to imidazole groups is 1 depending on the charging ratio, and the polyoxyethylene glycol derivative is present in an amount of 50% by weight of the total weight. Furthermore, it is a crosslinked polymer and is insoluble in all solvents, but has good swelling properties in water. When a urea adsorption test was carried out using the adsorbent in the same manner as in Example 1, it was found that the urea adsorption was reduced to 37 mg urea/dl. Thus, it can be seen that even when 4-vinylimidazole is used as the unsaturated monomer having an imidazole group, the urea absorbent of the present invention exhibits high adsorption capacity.
実施例 5
メチルメタクリレート5g、1−ビニルイミダ
ゾール4.7g、アクリル酸3.6g、エチレングリコ
ールジメタクリレート1g、AIBN 0.1gを
DMF100mlに溶解し、実施例1と同法で尿素吸着
剤を調製した。赤外線吸収スペクトルにより、該
吸着剤にはカルボキシル基、イミダゾール基及び
メチルメタクリレート重合残基(C=O、1735cm
-1)が含まれている事が確認され、又その仕込み
比によりカルボキシル基とイミダゾール基とメチ
ルメタクリレート重合残基の数が1対1対1の比
で構成される重合体である。該重合体は架橋高分
子であり、あらゆる溶剤に不溶であるが、水に対
する膨潤性は良好である。該吸着剤を用いて実施
例1と同法で尿素吸着試験を実施したところ、35
mg尿素/dlにまで減少している事実が分つた。Example 5 5 g of methyl methacrylate, 4.7 g of 1-vinylimidazole, 3.6 g of acrylic acid, 1 g of ethylene glycol dimethacrylate, and 0.1 g of AIBN.
A urea adsorbent was prepared by dissolving in 100 ml of DMF and using the same method as in Example 1. Infrared absorption spectra revealed that the adsorbent contains carboxyl groups, imidazole groups, and methyl methacrylate polymerization residues (C=O, 1735 cm
-1 ), and it is a polymer composed of carboxyl groups, imidazole groups, and methyl methacrylate polymer residues in a 1:1:1 ratio depending on the charging ratio. The polymer is a crosslinked polymer and is insoluble in all solvents, but has good swelling properties in water. When a urea adsorption test was conducted using the adsorbent in the same manner as in Example 1, 35
It was found that the concentration had decreased to mg urea/dl.
又、上記メチルメタクリレートの代りにビニル
アセテート3.2gを用いて、カルボキシル基の数
とイミダゾール基の数とビニルアセテート重合残
基の数が1対1対1で構成される重合体を同法で
合成し尿素吸着剤を調製した。該吸着剤を用いて
実施例1と同法で尿素吸着試験を実施したとこ
ろ、38mg尿素/dlにまで減少している事実が分つ
た。このように、カルボキシル基、イミダゾール
基以外に他のエチレン性不飽和単量体重合残基が
存在した場合でも、本発明における尿素吸着剤は
高い吸着能を示すことが分る。 In addition, using 3.2 g of vinyl acetate instead of the above methyl methacrylate, a polymer in which the number of carboxyl groups, the number of imidazole groups, and the number of vinyl acetate polymerization residues were in a 1:1:1 ratio was synthesized by the same method. A urea adsorbent was prepared. When a urea adsorption test was conducted using the adsorbent in the same manner as in Example 1, it was found that the adsorption amount was reduced to 38 mg urea/dl. Thus, it can be seen that the urea adsorbent of the present invention exhibits high adsorption capacity even when other ethylenically unsaturated monomer polymerization residues are present in addition to carboxyl groups and imidazole groups.
実施例 6
スチレン30g、1−ビニルイミダゾール9.4g、
アクリル酸7.5g、AIBN 0.1gをDMF100mlに溶
解し、実施例1と同法で尿素吸着剤を調製した。
該吸着剤は非架橋重合体であり、DMF、ジメチ
ルアセトアミド等の溶剤には可溶であるが、水、
メタノール、エタノールには不溶の重合体であ
る。又、該吸着剤の数平均分子量は約12000であ
り、赤外線吸収スペクトルにより、カルボキシル
基とイミダゾール基の存在が確認され、又その非
は仕込み比から1と考えられる。該吸着剤を用い
て実施例1と同法で尿素吸着試験を実施したこ
ろ、41mg尿素/dlにまで減少している事実が分つ
た。本実施例に用いた吸着剤は、ポリスチレンを
主成分とする非架橋重合体であり、架橋重合体に
比して水に対する膨潤性は大であり、このものに
おいても尿素吸着能は優れていることが分る。Example 6 30 g of styrene, 9.4 g of 1-vinylimidazole,
A urea adsorbent was prepared in the same manner as in Example 1 by dissolving 7.5 g of acrylic acid and 0.1 g of AIBN in 100 ml of DMF.
The adsorbent is a non-crosslinked polymer and is soluble in solvents such as DMF and dimethylacetamide, but is soluble in water,
It is a polymer that is insoluble in methanol and ethanol. Further, the number average molecular weight of the adsorbent is about 12,000, and the presence of carboxyl groups and imidazole groups was confirmed by infrared absorption spectrum, and their absence is considered to be 1 based on the charging ratio. When a urea adsorption test was carried out using the adsorbent in the same manner as in Example 1, it was found that the adsorption amount had decreased to 41 mg urea/dl. The adsorbent used in this example is a non-crosslinked polymer whose main component is polystyrene, which has a higher swelling property in water than a crosslinked polymer, and also has excellent urea adsorption ability. I understand.
比較例
1−ビニルイミダゾール10g、エチレングリコ
ールジメタクリレート1g、AIBN 0.03gを
DMF50mlに溶解し、実施例1と同法で重合を行
い尿素吸着剤を調製した。該吸着剤を用いて実施
例1と同法で尿素吸着試験を実施でしたところ、
尿素濃度は試験後も100mg尿素/dlであり、全く
変化は見られなかつた。該重合体はカルボキシル
基は無く、イミダゾール基のみであり、全く尿素
吸着能が無い事実が分つた。又、該重合体はあら
ゆる重合体に不溶であるが、水に対する膨純性も
悪く、尿素吸着剤に適していない。又、上記1−
ビニルイミダゾールの代りにアクリル酸10gを用
いて実施例1と同法で重合を行い尿素吸着剤を調
製した。該吸着剤を用いて実施例1と同法で尿素
吸着試験を実施したところ、吸湿性が非常に大で
あり、取り扱いに困難な上、尿素濃度は60mg尿
素/dlにまでしか減少しない事実が分つた。該重
合体はイミダゾール基は無く、カルボキシル基の
みである。Comparative example 1-vinylimidazole 10g, ethylene glycol dimethacrylate 1g, AIBN 0.03g
It was dissolved in 50 ml of DMF and polymerized in the same manner as in Example 1 to prepare a urea adsorbent. When a urea adsorption test was conducted using the adsorbent in the same manner as in Example 1,
The urea concentration remained 100 mg urea/dl even after the test, and no change was observed. It was found that the polymer had no carboxyl groups, only imidazole groups, and had no urea adsorption ability at all. Further, although this polymer is insoluble in all polymers, it also has poor swelling property in water and is not suitable as a urea adsorbent. Also, above 1-
A urea adsorbent was prepared by polymerizing in the same manner as in Example 1 using 10 g of acrylic acid instead of vinyl imidazole. When a urea adsorption test was carried out using the adsorbent in the same manner as in Example 1, it was found that it had very high hygroscopicity and was difficult to handle, and that the urea concentration could only be reduced to 60 mg urea/dl. Divided. This polymer has no imidazole group and only carboxyl groups.
これらの事実からカルボキシル基のみ、もしく
はイミダゾール基のみ存在する重合体は、本発明
における尿素吸着剤として不適であることが分
る。 These facts indicate that polymers containing only carboxyl groups or only imidazole groups are unsuitable as urea adsorbents in the present invention.
本発明の高分子尿素吸着剤は、カルボキシル基
及びイミダゾール基を共に含有するものであり、
高性能の尿素機能を有し、尿素の吸着、分離の必
要なあらゆる分野に適用でき、特に吸着型人工腎
臓やセンサーに応用可能である。
The polymer urea adsorbent of the present invention contains both a carboxyl group and an imidazole group,
It has a high-performance urea function and can be applied to all fields that require urea adsorption and separation, and is particularly applicable to adsorption-type artificial kidneys and sensors.
Claims (1)
ゾール基 (式中、R1は水素または炭素数5以下の炭化水
素基を表す。) を構成成分として含有し、必要に応じて架橋剤に
より架橋したエチレン性不飽和単量体の重合体で
あつて、カルボキシル基の数とイミダゾール基の
数との比(カルボキシル基/イミダゾール基)が
0.1乃至0.8であることを特徴とする高分子尿素吸
着剤。 2 カルボキシル基、 一般式(1)で示されるイミダゾール基 (式中、R1は水素または炭素数5以下の炭化水
素基を表す。)、及び 一般式(2) 〔−(CH2−)oO−〕nR2 (2) (式中nは2乃至5の整数、mは3以上の整数を
表し、R2は水素またはメチル基を表す。)で示さ
れるポリオキシアルキレングリコール誘導体基 を構成成分として含有し、必要に応じて架橋剤に
より架橋したエチレン性不飽和単量体の重合体で
あつて、カルボキシル基の数とイミダゾール基の
数との比(カルボキシル基/イミダゾール基)
が、0.1乃至8.0であることを特徴とする高分子尿
素吸着剤。[Claims] 1. Carboxyl group and imidazole group represented by general formula (1) (In the formula, R 1 represents hydrogen or a hydrocarbon group having 5 or less carbon atoms.) A polymer of ethylenically unsaturated monomers that contains as a constituent component and is crosslinked with a crosslinking agent as necessary. , the ratio of the number of carboxyl groups to the number of imidazole groups (carboxyl group/imidazole group) is
A polymer urea adsorbent characterized by having a molecular weight of 0.1 to 0.8. 2 carboxyl group, imidazole group represented by general formula (1) (In the formula, R 1 represents hydrogen or a hydrocarbon group having 5 or less carbon atoms.), and General formula (2) [-(CH 2 -) o O-] n R 2 (2) (In the formula, n is Contains a polyoxyalkylene glycol derivative group represented by an integer of 2 to 5, m represents an integer of 3 or more, and R2 represents hydrogen or a methyl group as a constituent component, and can be crosslinked with a crosslinking agent as necessary. A polymer of ethylenically unsaturated monomers, the ratio of the number of carboxyl groups to the number of imidazole groups (carboxyl group/imidazole group)
is from 0.1 to 8.0.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61202661A JPS6359353A (en) | 1986-08-30 | 1986-08-30 | High-molecular urea adsorbent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61202661A JPS6359353A (en) | 1986-08-30 | 1986-08-30 | High-molecular urea adsorbent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6359353A JPS6359353A (en) | 1988-03-15 |
JPH0443697B2 true JPH0443697B2 (en) | 1992-07-17 |
Family
ID=16461047
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61202661A Granted JPS6359353A (en) | 1986-08-30 | 1986-08-30 | High-molecular urea adsorbent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6359353A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013528103A (en) * | 2010-06-07 | 2013-07-08 | フレゼニウス メディカル ケア ホールディングス インコーポレイテッド | Urea adsorbent |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6861473B2 (en) | 2003-02-28 | 2005-03-01 | Baxter International Inc. | Macromolecular ketoaldehydes |
JP5233146B2 (en) * | 2007-03-30 | 2013-07-10 | 栗田工業株式会社 | ORGANIC UREA COMPOUND ADSORBENT, ORGANIC UREA COMPOUND ADSORBING DEVICE, AND ORGANIC UREA COMPOUND TREATMENT METHOD |
US8220643B2 (en) * | 2008-06-06 | 2012-07-17 | Fresenius Medical Care Holdings, Inc. | Urea sorbent |
US20120032093A1 (en) | 2010-08-03 | 2012-02-09 | Kemira Chemicals Inc. | Tagged scale inhibitor compositions and methods of inhibiting scale |
-
1986
- 1986-08-30 JP JP61202661A patent/JPS6359353A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013528103A (en) * | 2010-06-07 | 2013-07-08 | フレゼニウス メディカル ケア ホールディングス インコーポレイテッド | Urea adsorbent |
Also Published As
Publication number | Publication date |
---|---|
JPS6359353A (en) | 1988-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5717766B2 (en) | Thermoplastic nanocomposite materials based on nanocrystalline cellulose (NCC) | |
US6303702B1 (en) | Method of producing material for purification of physiological liquids of organism | |
US20050159508A1 (en) | Hemocompatible coated polymer and related one-step methods | |
CN117123198A (en) | Modification method of blood purification adsorption material | |
CA1274341A (en) | Water absorbing resins, their manufacture and their use in the production of aqueous fluid absorbent articles | |
JPH0443697B2 (en) | ||
EP0217062B1 (en) | Urea adsorbent | |
US20040076845A1 (en) | Hemocompatible polymer systems & related methods | |
JPS61264006A (en) | Production of highly water-absorbing polymer | |
CN113351185A (en) | Microsphere adsorbent for removing toxin through blood perfusion and preparation method thereof | |
WO2018211389A1 (en) | Molecularly imprinted polymers for selective adsorption of urea for dialysis | |
JPH0117412B2 (en) | ||
JP3285441B2 (en) | Adsorbent for lowering plasma viscosity of vasoocclusive disease plasma and apparatus for lowering plasma viscosity | |
JP3446274B2 (en) | Manufacturing method of separation agent | |
JPS6361007A (en) | Urea-decomposing metal complex resin | |
JPH07100375A (en) | High-density large surface area adsorbent | |
JPH04247236A (en) | Highly cross-linked pearl-like hydrophobic support material capable of being activated, method for modifying said support material and method for adsorbing biologically active substance from watery liouid or chromatograph- ing for removal of large amount of said substance | |
JP3323558B2 (en) | Manufacturing method of super absorbent resin | |
JP3119897B2 (en) | Method for producing water-soluble or water-swellable polymer | |
JP3316915B2 (en) | Separation resin and production method thereof | |
JPS6090040A (en) | Synthetic adsorbent and preparation thereof | |
CN117736371A (en) | Protein-loadable hydrogel microsphere and preparation method and application thereof | |
JPH0834894A (en) | Poly(acrylic acid) composite | |
JPS6215561B2 (en) | ||
JP2969848B2 (en) | Hydrophilic crosslinked copolymer particles |